DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4

Fumiyuki Sanematsu, Masanori Hirashima, Mélanie Laurin, Ryosuke Takii, Akihiko Nishikimi, Keiko Kitajima, Guo Ding, Mamiko Noda, Yuzo Murata, Yoshihiko Tanaka, Sadahiko Masuko, Toshio Suda, Chikara Meno, Jean François Côté, Takashi Nagasawa, Yoshinori Fukui

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Rationale: During embryogenesis, the CXC chemokine ligand (CXCL)12 acts on endothelial cells to control cardiac development and angiogenesis. Although biological functions of CXCL12 are exerted in part through activation of the small GTPase Rac, the pathway leading from its receptor CXC chemokine receptor (CXCR)4 to Rac activation remains to be determined. Objective: DOCK180 (dedicator of cytokinesis), an atypical Rac activator, has been implicated in various cellular functions. Here, we examined the role of DOCK180 in cardiovascular development. Methods and Results: DOCK180 associates with ELMO (engulfment and cell motility) through the N-terminal region containing a Src homology 3 domain. We found that targeted deletion of the Src homology 3 domain of DOCK180 in mice leads to embryonic lethality with marked reduction of DOCK180 expression at the protein level. These mutant mice, as well as DOCK180-deficient mice, exhibited multiple cardiovascular abnormalities resembling those seen in CXCR4-deficient mice. In DOCK180 knocked down endothelial cells, CXCL12-induced Rac activation was impaired, resulting in a marked reduction of cell motility. Conclusions: These results suggest that DOCK180 links CXCR4 signaling to Rac activation to control endothelial cell migration during cardiovascular development.

Original languageEnglish
Pages (from-to)1102-1105
Number of pages4
JournalCirculation Research
Volume107
Issue number9
DOIs
Publication statusPublished - 2010 Oct 29

Fingerprint

Cell Movement
src Homology Domains
Endothelial Cells
Cardiovascular Abnormalities
CXCR4 Receptors
Multiple Abnormalities
CXC Chemokines
Cytokinesis
Monomeric GTP-Binding Proteins
Embryonic Development
Ligands
Proteins

Keywords

  • cardiovascular development
  • CXCL12
  • DOCK180
  • endothelial cells
  • Rac

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Sanematsu, F., Hirashima, M., Laurin, M., Takii, R., Nishikimi, A., Kitajima, K., ... Fukui, Y. (2010). DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4. Circulation Research, 107(9), 1102-1105. https://doi.org/10.1161/CIRCRESAHA.110.223388

DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4. / Sanematsu, Fumiyuki; Hirashima, Masanori; Laurin, Mélanie; Takii, Ryosuke; Nishikimi, Akihiko; Kitajima, Keiko; Ding, Guo; Noda, Mamiko; Murata, Yuzo; Tanaka, Yoshihiko; Masuko, Sadahiko; Suda, Toshio; Meno, Chikara; Côté, Jean François; Nagasawa, Takashi; Fukui, Yoshinori.

In: Circulation Research, Vol. 107, No. 9, 29.10.2010, p. 1102-1105.

Research output: Contribution to journalArticle

Sanematsu, F, Hirashima, M, Laurin, M, Takii, R, Nishikimi, A, Kitajima, K, Ding, G, Noda, M, Murata, Y, Tanaka, Y, Masuko, S, Suda, T, Meno, C, Côté, JF, Nagasawa, T & Fukui, Y 2010, 'DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4', Circulation Research, vol. 107, no. 9, pp. 1102-1105. https://doi.org/10.1161/CIRCRESAHA.110.223388
Sanematsu F, Hirashima M, Laurin M, Takii R, Nishikimi A, Kitajima K et al. DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4. Circulation Research. 2010 Oct 29;107(9):1102-1105. https://doi.org/10.1161/CIRCRESAHA.110.223388
Sanematsu, Fumiyuki ; Hirashima, Masanori ; Laurin, Mélanie ; Takii, Ryosuke ; Nishikimi, Akihiko ; Kitajima, Keiko ; Ding, Guo ; Noda, Mamiko ; Murata, Yuzo ; Tanaka, Yoshihiko ; Masuko, Sadahiko ; Suda, Toshio ; Meno, Chikara ; Côté, Jean François ; Nagasawa, Takashi ; Fukui, Yoshinori. / DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4. In: Circulation Research. 2010 ; Vol. 107, No. 9. pp. 1102-1105.
@article{1365dcd0893d4efca79755b25731e2c2,
title = "DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4",
abstract = "Rationale: During embryogenesis, the CXC chemokine ligand (CXCL)12 acts on endothelial cells to control cardiac development and angiogenesis. Although biological functions of CXCL12 are exerted in part through activation of the small GTPase Rac, the pathway leading from its receptor CXC chemokine receptor (CXCR)4 to Rac activation remains to be determined. Objective: DOCK180 (dedicator of cytokinesis), an atypical Rac activator, has been implicated in various cellular functions. Here, we examined the role of DOCK180 in cardiovascular development. Methods and Results: DOCK180 associates with ELMO (engulfment and cell motility) through the N-terminal region containing a Src homology 3 domain. We found that targeted deletion of the Src homology 3 domain of DOCK180 in mice leads to embryonic lethality with marked reduction of DOCK180 expression at the protein level. These mutant mice, as well as DOCK180-deficient mice, exhibited multiple cardiovascular abnormalities resembling those seen in CXCR4-deficient mice. In DOCK180 knocked down endothelial cells, CXCL12-induced Rac activation was impaired, resulting in a marked reduction of cell motility. Conclusions: These results suggest that DOCK180 links CXCR4 signaling to Rac activation to control endothelial cell migration during cardiovascular development.",
keywords = "cardiovascular development, CXCL12, DOCK180, endothelial cells, Rac",
author = "Fumiyuki Sanematsu and Masanori Hirashima and M{\'e}lanie Laurin and Ryosuke Takii and Akihiko Nishikimi and Keiko Kitajima and Guo Ding and Mamiko Noda and Yuzo Murata and Yoshihiko Tanaka and Sadahiko Masuko and Toshio Suda and Chikara Meno and C{\^o}t{\'e}, {Jean Fran{\cc}ois} and Takashi Nagasawa and Yoshinori Fukui",
year = "2010",
month = "10",
day = "29",
doi = "10.1161/CIRCRESAHA.110.223388",
language = "English",
volume = "107",
pages = "1102--1105",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - DOCK180 is a rac activator that regulates cardiovascular development by acting downstream of CXCR4

AU - Sanematsu, Fumiyuki

AU - Hirashima, Masanori

AU - Laurin, Mélanie

AU - Takii, Ryosuke

AU - Nishikimi, Akihiko

AU - Kitajima, Keiko

AU - Ding, Guo

AU - Noda, Mamiko

AU - Murata, Yuzo

AU - Tanaka, Yoshihiko

AU - Masuko, Sadahiko

AU - Suda, Toshio

AU - Meno, Chikara

AU - Côté, Jean François

AU - Nagasawa, Takashi

AU - Fukui, Yoshinori

PY - 2010/10/29

Y1 - 2010/10/29

N2 - Rationale: During embryogenesis, the CXC chemokine ligand (CXCL)12 acts on endothelial cells to control cardiac development and angiogenesis. Although biological functions of CXCL12 are exerted in part through activation of the small GTPase Rac, the pathway leading from its receptor CXC chemokine receptor (CXCR)4 to Rac activation remains to be determined. Objective: DOCK180 (dedicator of cytokinesis), an atypical Rac activator, has been implicated in various cellular functions. Here, we examined the role of DOCK180 in cardiovascular development. Methods and Results: DOCK180 associates with ELMO (engulfment and cell motility) through the N-terminal region containing a Src homology 3 domain. We found that targeted deletion of the Src homology 3 domain of DOCK180 in mice leads to embryonic lethality with marked reduction of DOCK180 expression at the protein level. These mutant mice, as well as DOCK180-deficient mice, exhibited multiple cardiovascular abnormalities resembling those seen in CXCR4-deficient mice. In DOCK180 knocked down endothelial cells, CXCL12-induced Rac activation was impaired, resulting in a marked reduction of cell motility. Conclusions: These results suggest that DOCK180 links CXCR4 signaling to Rac activation to control endothelial cell migration during cardiovascular development.

AB - Rationale: During embryogenesis, the CXC chemokine ligand (CXCL)12 acts on endothelial cells to control cardiac development and angiogenesis. Although biological functions of CXCL12 are exerted in part through activation of the small GTPase Rac, the pathway leading from its receptor CXC chemokine receptor (CXCR)4 to Rac activation remains to be determined. Objective: DOCK180 (dedicator of cytokinesis), an atypical Rac activator, has been implicated in various cellular functions. Here, we examined the role of DOCK180 in cardiovascular development. Methods and Results: DOCK180 associates with ELMO (engulfment and cell motility) through the N-terminal region containing a Src homology 3 domain. We found that targeted deletion of the Src homology 3 domain of DOCK180 in mice leads to embryonic lethality with marked reduction of DOCK180 expression at the protein level. These mutant mice, as well as DOCK180-deficient mice, exhibited multiple cardiovascular abnormalities resembling those seen in CXCR4-deficient mice. In DOCK180 knocked down endothelial cells, CXCL12-induced Rac activation was impaired, resulting in a marked reduction of cell motility. Conclusions: These results suggest that DOCK180 links CXCR4 signaling to Rac activation to control endothelial cell migration during cardiovascular development.

KW - cardiovascular development

KW - CXCL12

KW - DOCK180

KW - endothelial cells

KW - Rac

UR - http://www.scopus.com/inward/record.url?scp=78349310110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349310110&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.223388

DO - 10.1161/CIRCRESAHA.110.223388

M3 - Article

C2 - 20829512

AN - SCOPUS:78349310110

VL - 107

SP - 1102

EP - 1105

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 9

ER -